CD8+ CD28- regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study
Related Research units
Bibliographical data
Original language | English |
---|---|
ISSN | 0887-6924 |
DOIs | |
Publication status | Published - 07.2024 |
PubMed | 38830959 |
---|